Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,821 | 5,548 | 6,237 | 5,815 | 8,317 |
| Receivables | 21,834 | 18,340 | 17,391 | 17,074 | 17,766 |
| Inventories | 27,587 | 25,978 | 24,709 | 22,676 | 22,262 |
| Other current assets | 4,341 | 5,820 | 5,220 | 3,658 | 3,355 |
| TOTAL | $61,583 | $55,686 | $53,557 | $49,223 | $51,700 |
| Non-Current Assets | |||||
| PPE Net | 3,415 | 3,453 | 3,429 | 3,699 | 3,960 |
| Intangibles | 85,074 | 86,928 | 88,934 | 90,107 | 91,741 |
| Other Non-Current Assets | 12,272 | 7,805 | 8,051 | 8,220 | 8,853 |
| TOTAL | $100,761 | $98,186 | $100,414 | $102,026 | $104,554 |
| Total Assets | $162,344 | $153,872 | $153,971 | $151,249 | $156,254 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,235 | 2,470 | 2,220 | 1,970 | 1,721 |
| Accounts payable and accrued liabilities | 4,911 | 5,616 | 7,489 | 6,416 | 5,972 |
| Other current liabilities | 10,762 | 9,670 | 7,823 | 6,635 | 7,478 |
| TOTAL | $25,316 | $23,506 | $23,268 | $20,718 | $21,053 |
| Non-Current Liabilities | |||||
| Long Term Debt | 45,095 | 42,740 | 40,921 | 41,600 | 46,286 |
| Deferred Revenues | 4,266 | 3,623 | 3,675 | 3,637 | 3,771 |
| Other Non-Current Liabilities | 6,974 | 9,190 | 9,509 | 10,007 | 10,335 |
| TOTAL | $53,627 | $53,479 | $52,002 | $53,416 | $58,520 |
| Total Liabilities | $78,943 | $76,985 | $75,270 | $74,134 | $79,573 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,230 | 40,811 | 40,763 | 39,957 | 39,826 |
| Common Shares | 452 | 451 | 451 | 448 | 444 |
| Retained earnings | -132,674 | -133,635 | -133,465 | -133,055 | -132,386 |
| Other shareholders' equity | -10,027 | -15,003 | -13,868 | -14,059 | -12,734 |
| TOTAL | $83,401 | $76,887 | $78,701 | $77,115 | $76,681 |
| Total Liabilities And Equity | $162,344 | $153,872 | $153,971 | $151,249 | $156,254 |